𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas

✍ Scribed by Maria I. Patrikis; Emma J. Bryan; Nicola A. Thomas; Greg E. Rice; Michael A. Quinn; Mark S. Baker; Ian G. Campbell


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
85 KB
Volume
37
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Leiomyomas are the most common gynecologic tumors in women, but very little is known about their molecular pathology. We used single‐stranded conformational polymorphism/heteroduplex analysis to analyze 42 unselected uterine leiomyomas for somatic mutations in all coding exons of the gene encoding CCAAT displacement protein (CDP), as well as exons 5–8 of TP53 and codons 1–36 and 38–80 of KRAS. No somatic mutations were identified in either TP53 or KRAS, indicating that disregulation of these genes is not required for leiomyomas development. Aberrant band shifts were identified in CDP, but these were all germline nonpathogenic variants that have been reported previously. There is good functional and genetic evidence indicating that CDP is a leiomyoma suppressor, but our data suggested that somatic mutations in this gene were rare in unselected uterine leiomyomas. It is possible that CDP belongs to a class of tumor suppressor in which loss of only one copy of the gene, either by genetic or epigenetic mechanisms, is sufficient to allow tumor growth. Β© 2003 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Somatic mutations of the APC, KRAS, and
✍ RenΓ© van Wyk; Premysl Slezak; Vanessa M. Hayes; Charles H.C.M. Buys; Maritha J. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 113 KB πŸ‘ 2 views

Colorectal adenomas are macroscopically visible morphological changes of the mucosa that can develop focal carcinoma in the absence of surgical intervention. The successive molecular changes proposed to occur at different stages in the adenomacarcinoma sequence were primarily based on DNA studies of

Molecular and cytogenetic analysis of ch
✍ Dr. C. S. Ishwad; R. E. Ferrell; J. Davare; A. M. Meloni; A. A. Sandberg; U. Sur πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 393 KB

Uterine leiomyomas are benign tumors that arise clonally from smooth muscle cells of the myometrium. Cytogenetic studies of uterine leiomyomas have shown that about 40% have chromosome abnormalities and that deletion of 7q is a common finding. The observations suggest the possible location of a grow

Expression of N-terminally truncated iso
✍ Nam Sung Moon; Wendy Rong Zeng; Peter Premdas; Marianne Santaguida; Ginette BΓ©ru πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 162 KB

## Abstract Genetic analyses and mRNA expression studies have implicated __CUTL1__ as a candidate tumor‐suppressor gene in uterine leiomyomas and breast cancers. However, modulation of CDP/Cux, the protein encoded by __CUTL1,__ does not agree with this notion. The activity of CDP/Cux, which is the

MUT-TP53 2.0: a novel versatile matrix f
✍ Thierry Soussi; Dalil Hamroun; Linn Hjortsberg; Jean Michel Rubio-Nevado; Jean L πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 240 KB

Analysis of the literature reporting p53 mutations shows that 8% of report display typographical mistakes with a notable increase in recent years. These errors are sometimes isolated, but in some cases, they concern several or even all mutations described in a single article. Furthermore, some works

TP53 mutation and haplotype analysis of
✍ Jaclyn Hung; Betsy Mims; Guillermina Lozano; Louise Strong; Carolyn Harvey; Tina πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 275 KB

Two large apparently unrelated African American families with a high incidence of breast cancer and other tumors characteristic of Li-Fraumeni breast sarcoma cancer family syndrome were studied. Mutation screening revealed that in both families the affected members carried a germline mutation of the